URO-TRACK CME FACULTY & SPEAKERS

KEYNOTE SPEAKER & PROGRAM CHAIRS

Deepak Kapoor

Deepak Kapoor

MD
Keynote Speaker

Biography

Dr. Deepak A. Kapoor, Chairman and Chief Executive Officer of Integrated Medical Professionals (IMP) and President of Farmingdale, NY based Advanced Urology Centers of New York, is one of the youngest physicians to have been certified by the American Board of Urology His medical background is diverse with both laboratory and clinical experience, both in the academic and independent practice. Dr. Kapoor´s expertise includes basic science research in molecular biology as well as extensive experience in oncologic and reconstructive surgery.

Under his leadership, Integrated Medical Professionals (IMP) has become the largest independent comprehensive urology group practice in the United States and is regarded as a national leader in the areas of quality management, utilization review, compliance and the development of coordinated clinical pathways.

Dr. Kapoor is Clinical Professor of Urology at the Icahn School of Medicine at Mount Sinai, Chairman of Health Policy and Past President of LUGPA, and Chairman of medical liability insurance company SCRUBS RRG. Prior leadership roles include serving as a Director of UroPAC and as past Chairman of Access to Integrated Cancer Care. Dr. Kapoor was founder of the New York Urology Trade Association as well as the non-profit Integrated Medical Foundation. Dr. Kapoor is a Fellow of the American College of Physician Executives.

Dr. Kapoor has published and lectured extensively on both clinical and business medical issues, and serves on a number of medical advisory boards, including the New York State Governor´s Prostate Cancer Advisory Panel. He is the 2014 recipient of the Russell W. Lavengood Distinguished Service Award from the New York Section of the American Urological Association as well as the 2011 Ambrose-Reed AUA Socioeconomic Essay Award. Dr. Kapoor is listed in the Castle-Connolly guide of Best Doctors and continues to enjoy an active clinical practice along with his administrative duties.

Mitchell C. Benson

Mitchell C. Benson

MD
Program Chair

Biography

Dr. Mitchell C. Benson began his affiliation with Columbia University College of Physicians and Surgeons in the Autumn of 1973 when he enrolled in Columbia P & S as a first year medical student. He recognized early in his training that he wished to pursue a career in Urology and following an internship and residency in general surgery at Mount Sinai Hospital in New York, he became a resident in Urology at The Presbyterian Hospital in New York in 1979. Following his chief residency in Urology at The Presbyterian Hospital, he went to Johns Hopkins Hospital and University where he was a Research Fellow in Urologic Oncology from 1982-1984.

After completion of his fellowship, Dr. Benson returned to Columbia University P & S where he joined the Urology faculty. Dr. Benson was one of the first recipients of the Herbert Irving Assistant Professor awards and he was the Herbert Irving Assistant Professor of Urology from July 1988 – June 1991. He was then promoted to Associate Professor of Urology, and in July 1995 to Professor of Urology. In 1997, he was named the George F. Cahill Professor of Urology. In November 2003, he was named the Director of the Comprehensive Cancer Center of Columbia University. In August 2005, he was appointed The George F. Cahill Professor and Chairman of the Department of Urology and Urologist-in-Chief at Columbia University Medical Center.

During his career, Dr. Benson has been the recipient of numerous Honors. After having been elected to Phi Beta Kappa at Union College, he was awarded the Urology Prize from Columbia University College of Physicians and Surgeons. During his residency, he was awarded 1st Prize at the New York Academy of Medicine in the Ferdinand C. Valentine Residents’ Essay Contest. He has won prizes for his clinical research from the American Urological Association in 1987 and 1991.

Dr. Benson’s research has been and continues to be supported by the National Cancer Institute and he has participated in numerous projects sponsored by the pharmaceutical industry. He has submitted or published 195 scientific articles since 1984. He has presented more than 200 papers at National Meetings.

Michael Blute

Michael Blute

MD
Program Chair

Biography

Chief of Urology,Massachusetts General Hospital
Walter S. Kerr, Jr., Professor of Surgery
Harvard Medical School

Dr. Michael L. Blute received his BA Degree from the College of the Holy Cross in Worcester, and his MD Degree from Creighton University School of Medicine in 1982, graduating Magna Cum Laude. Subsequent to internship and residency in urology at the Mayo Clinic in Rochester, he remained on the staff and rose rapidly through the ranks to become the Anson L. Clark Professor and Chairman in the Department of Urology in 1999. He remained as Chairman of the Department of Urology and on the Executive Board of the Mayo Clinic until appointed Interim Chief of Urology and Director of the Cancer Center of Excellence at the University of Massachusetts Memorial Medical Center in 2010. In April 2012 Dr. Blute was appointed Chief of Urology at The Massachusetts General Hospital in Boston and is the Walter S. Kerr, Jr. Professor of Surgery, Harvard Medical School.

Dr. Blute has had a major interest in urologic oncology and is well-known in the field of academic urology. His major areas of interest include prostate cancer, nephron-sparing surgery for kidney masses, and the management of complex renal cell and bladder neoplasms. He has been involved in phase III trials of Finasteride, chemoprevention of prostatic intraepithelial neoplasia with anti-androgens, minimally invasive surgery for BPH, biomarkers in prostate cancer, and discovery of B7 family of “Check Point Inhibitor” Biomarkers in kidney cancer. He serves as a reviewer on 13 editorial boards. He serves on the AUA Renal Mass Guideline Panel and served on the American Joint Committee on Cancer. He is the recipient of the 2010 AUA Career Contribution Award. He has been honored as Department of Urology Teacher of the Year at the Mayo Clinic on several occasions. His bibliography includes 394 peer-reviewed publications, one book, and 34 book chapters.

Adam Feldman

Adam Feldman

MD, MPH
Program Chair

Biography

Dr. Adam Feldman is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. Dr. Feldman completed his residency in urology in 2006 and subsequently completed his fellowship in urologic oncology in June 2008. His clinical practice is focused on the surgical management of genitourinary cancer using both open and laparoscopic techniques. Dr. Feldman also is involved in clinical and translational research in cancers of the prostate, bladder, kidney and penis. He recently received a three year Young Investigator Award from the Prostate Cancer Foundation for his work in biomarker discovery and analysis in prostate cancer.

Phillip Pierorazio

Phillip Pierorazio

MD
Program Chair

Biography

Dr. Phillip Pierorazio is an Associate Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University. Dr. Pierorazio is originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City where he completed a Doris Duke Clinical Research Fellowship in Urologic Oncology.

Dr. Pierorazio has expertise in all malignancies of the urinary tract and performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, adrenal, bladder, prostate and retroperitoneal lymph node dissection for testicular cancer. He has a special interest in kidney cancer, including partial nephrectomy for early-stage disease, and high-risk surgeries for patients with advanced cancers.

His research interests parallel his clinical practice, including high-risk prostate and urothelial cancer. He has a special interest in testicular and kidney cancer (renal cell carcinoma), studying both advanced and early-stage disease. He runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry – one of the largest active surveillance registries for patients with small kidney tumors. He sits on both the AUA and National Comprehensive Cancer Network (NCCN) Guidelines Committees for Kidney Cancer. He is also the Director of the Division of Testicular Cancer, a member of the NCCN Guidelines committee, and works with a number of testicular cancer advocacy groups around the country. He runs the testicular cancer “Go-Team” and coordinates the departments research efforts in testicular cancer.

Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest, NCCN Young Investigator Award, and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.

Alan Partin

Alan Partin

MD, PhD
Program Chair

Biography

Alan W. Partin, M.D., Ph.D., is the author or co-author of more than 500 scientific articles, serves on numerous editorial boards and is editor-in-chief of Urology Case Reports and editor of the Campbell-Walsh urology text. He has been honored with many awards, including the Hopkins Young Investigators Award, the Pfizer Scholars in Urology Award in 1996, and the “Gold- Cystoscope” award in 2001. In 2004, Dr. Partin was named director of the Department of Urology at the Brady Urological Institute and urologist-in-chief of The Johns Hopkins Hospital.

Dr. Partin is an expert in assessing prognosis and making predictions for men with prostate cancer. The creation of The Partin Tables, which can predict with 95 percent accuracy a man’s likelihood of being cured by treatment, made his research famous. Dr. Partin’s laboratories and clinical and surgical interests focus on developing and testing new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.

Dr. Partin’s laboratories have investigated many new “PSA-like” serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basic science investigation of new proteins—which may help in detection—and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques for treatment of this common disease in men.

Dr. Partin received his undergraduate degree in chemistry from the University of Mississippi where he was an Academic All-American football player. He received his medical degree and his Ph.D. in pharmacology and molecular sciences from Johns Hopkins University where he continued his post-doctoral training.

FACULTY

Mohamad Allaf

Mohamad Allaf

MD
Faculty

Biography

Dr. Mohamad Allaf is an Associate Professor of Urology, Oncology, and Biomedical Engineering at the Brady Urological Institute and Director of Minimally Invasive and Robotic Urological Surgery at the Johns Hopkins Hospital. He joined the staff after receiving his undergraduate and medical degrees from the Johns Hopkins University and completing his residency and advanced training in Urology at Johns Hopkins, as well.

As a urologic oncologist, his main clinical focus includes the treatment of kidney tumors and prostate cancer. While expert in both open and minimally invasive surgery, he specializes in ROBOTIC approaches to these diseases and is amongst the busiest robotic surgeons in the world. The following is a list of robotic procedures he performs on a regular basis:

1. Nerve-Sparing Radical Prostatectomy

2. Partial and Radical Nephrectomy

3. Pyeloplasty

4. Adrenalectomy

5. Retroperitoneal Lymph Node Dissection (for testicular cancer patients)

Dr. Allaf also runs a research laboratory aimed at decreasing the morbidity associated with the treatment of urologic cancers. He oversees a large registry of patients who have small kidney tumors and elect for careful and active observation. Additionally, given his background as a biomedical engineer, he is a leader in developing future technological advancements in the field of robotic and minimally invasive surgery. An example of this is the use of real-time elastography imaging during robotic prostatectomy to regain tactile feedback during this delicate procedure. Dr. Allaf has been the recipient of numerous academic awards and has been invited nationally and internationally to demonstrate robotic surgery and lecture on robotic prostatectomy and kidney surgery. He has written and published numerous research articles, textbook chapters, patents and video presentations in the field of Laparoscopic and Robotic Urologic Surgery.

Gina Badalato

Gina Badalato

MD
Faculty

Biography

Gina M. Badalato, M.D., Assistant Professor of Urology, joined our faculty in December 2014 as part of the clinical team serving general urology patients. A graduate of Columbia University College of Physicians and Surgeons and one of the Department’s former residents and clinical fellows, Dr. Badalato specializes in voiding dysfunction, female urology, and stone disease. In addition to seeing patients, Dr. Badalato plays an important role in the Department’s education mission by serving as Director of Medical Education, Associate Program Director, and advisor to Columbia P&S students. Dr. Badalato has research interest stone disease, voiding dysfunction and medical education outcomes. She has co-authored numerous articles on these and other topics in urology.

Marisa Clifton

Marisa Clifton

MD
Faculty

Biography

Dr. Marisa Clifton is the Director of Women’s Health at the Brady Urological Institute. She is fellowship trained and board certified in Urology with subspecialty certification in Female Pelvic Medicine and Reconstructive Surgery.

As a leader in the field of female urology, her clinical expertise includes surgical and nonsurgical treatment of pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, urinary fistulas, genitourinary reconstruction and urethral diverticula.

Dr. Clifton is also an Assistant Professor of Urology at the Johns Hopkins School of Medicine and serves as the Urology Residency Program Director and the Director of Robotic Education. Her research interests include medical education and clinical outcomes after surgery.

Dr. Clifton received her medical degree from the Johns Hopkins University School of Medicine and completed her residency in urology at the Mayo Clinic in Rochester, Minnesota. She completed her fellowship in Female Pelvic Medicine and Reconstructive Surgery at The Cleveland Clinic in Cleveland, Ohio.

Elise De

Elise De

MD
Faculty

Biography

Dr. Elise De is a Female Pelvic Medicine and Reconstructive Surgeon with the Massachusetts General Hospital Department of Urology, and part of the MGH Pelvic Floor Disorders Center. From 2005-2017 she was at Albany Medical Center, most recently Associate Professor and Medical Director of the Albany Pelvic Health Center. She Chairs the International Continence Society Education Committee and serves on the ICS Ethics Committee as well as the Publications Committee of IUGA. Her residency was in Urology at Boston University and fellowship in Pelvic Medicine and Reconstructive Surgery at UT Houston, MD Anderson, and TIRR. Her clinical practice is composed of incontinence, prolapse, neurogenic bladder, and voiding dysfunction in men and women. She has recently co-edited the book “Native Tissue Repair in Incontinence and Prolapse”. She has published and spoken on multiple topics including multidisciplinary systems of care, prolapse, neurogenic bladder, rabbit models of pelvic floor dystonia and cross-innervation of the bladder, quantification of human pelvic floor tone, and urodynamic outcomes in serial long-term Botox.

Brian Eisner

Brian Eisner

MD
Faculty

Biography

Dr. Brian Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones, and laparoscopic surgery. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease, and surgical treatment of kidney stones.

Jack Elder

Jack Elder

MD, FACS
Faculty

Biography

Jack S. Elder, M.D., FACS, is Chief of Pediatric Urology, MassGeneral Hospital for Children. Dr. Elder received an M.D. with distinction from the University of Oklahoma College of Medicine, and was Vice President of Alpha Omega Alpha. He completed general surgery training at Yale-New Haven Hospital and a residency in urology at The Johns Hopkins Hospital. Dr. Elder completed pediatric urology fellowships at Johns Hopkins and Children’s Hospital of Philadelphia. He was Director of Pediatric Urology at Rainbow Babies and Children’s Hospital for 21 years, and tenured Carter Kissell Professor of Urology at Case Western University School of Medicine. Subsequently, Dr. Elder was appointed Chief of Urology and Chief of Pediatric Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. He joined Mass General in April 2015. Dr. Elder was the Pediatric Urology Section Editor of The Journal of Urology from 1998-2007. Currently, he is on the editorial board of European Urology, Pediatric Surgery International, BJU International, Annals of Urology, Clinical Urology, and International Scholarly Research Notices. Dr. Elder has served as President of the Society for Pediatric Urology and the American Academy of Pediatric Urologists. He was the Chairman of the first American Urological Association Pediatric Vesicoureteral Reflux Guidelines Committee, which published their recommendations in 1997, and was the facilitator of the second AUA Reflux Guidelines Committee, which published updated recommendations in 2010. He also is the Section Head, Pediatric Urology, AUA Online Robotic Surgery Handbook and is an annual reviewer for the European Association of Urology Paediatric Urology Guidelines. Dr. Elder has been Visiting Professor or Visiting Surgeon at 56 institutions and international medical centers. Dr. Elder has > 160 peer-reviewed publications, edited or authored 6 books, and 148 book chapters, and writes the pediatric urology section of the Nelson Textbook of Pediatrics.

Lunan Ji

Lunan Ji

MD
Faculty

Biography

Dr. Lunan Ji attended medical school at the State University of New York at Buffalo. He then went on to complete his urology residency at the University of Miami. Dr. Ji is currently a fellow in female urology and voiding dysfunction at Columbia University.

Brian Matlaga

Brian Matlaga

MD
Faculty

Biography

Dr. Brian Matlaga is Professor of Urology at the Johns Hopkins University School of Medicine and also serves as the Director of Ambulatory Care for the James Buchanan Brady Urological Institute. Dr. Matlaga received his undergraduate degree from Dartmouth College, and his Medical Degree and a Master of Public Health degree from Tulane University. He then completed his internship in surgery and residency in urology at Wake Forest University; his subsequent fellowship at Indiana University was supported by an American Foundation for Urologic Disease Research Scholarship.

Dr. Matlaga is an internationally recognized expert in the medical and surgical management of patients with urinary stone disease, and he is the Director of Stone Disease for the Brady Urological Institute. This expertise is built on his academic investigations of the pathophysiology and epidemiology of stone formation, as well as into the advancement of minimally invasive surgical techniques. A frequent contributor to the medical press, Dr. Matlaga’s research has received both national and international awards; most recently, he was the recipient of the Endourological Society’s 2014 Arthur D. Smith Endourology Lectureship. Dr. Matlaga sits on numerous editorial boards as well as advisory committees and Guidelines Panels for the American Urological Association, the American Board of Urology, the Endourological Society, and the National Institutes of Health.

James McKiernan

James McKiernan

MD
Faculty

Biography

James McKiernan, MD is the John K. Lattimer Professor and Chair of the Department of Urology of the College of Physicians and Surgeons and urologist-in-chief at NewYork-Presbyterian/Columbia. Columbia University /NewYork-Presbyterian’s urology program ranked No. 6 in the latest U.S. News & World Report ranking of America’s best hospitals and ranked 7th in NIH grant funding among academic Urology departments in America.

Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center.Dr. McKiernan specializes in urologic oncology, particularly surgical therapy in high-risk patients with bladder and kidney cancers. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. Dr. McKiernan’s research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 200 scientific articles and book chapters on urologic oncology. He has served as the Vice Chair for the AJCC TNM Staging Task Force, as well as the AUA Guidelines Panel on non-muscle invasive bladder cancer. In addition, Dr. McKiernan directs is the clinical trials program of experimental therapeutics in bladder cancer at Columbia University, which investigates new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia’s Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Jason Michaud

Jason Michaud

MD, PhD
Faculty

Biography

Jason E. Michaud MD, PhD is a Pediatric Urologist located at Massachusetts General Hospital for Children and Harvard Medical School. He has an interest in all types of genitourinary issues, with a special interest in neurogenic bladder, hypospadias, vesicouretral reflux, urinary tract infections, as well as major birth defects including spina bifida and bladder exstrophy. He completed his urology residency and fellowship in pediatric urology at The Johns Hopkins Hospital in Baltimore, Maryland. He conducts basic and clinical research in genitourinary birth defects, urinary tract infections, and urinary tract reconstruction. He currently sees patients at both Massachusetts General Hospital for Children and Newton Wellesley Hospital.

Ajay Nehra

Ajay Nehra

MD
Faculty

Biography

Dr. Ajay Nehra, board-certified urologist at Massachusetts General Hospital in Boston, MA, specializes in prostate enlargement, male sexual dysfunction, male incontinence, male infertility and Peyronie’s Disease. He is a former professor of urology at Mayo Clinic College of Medicine in Rochester, MN, and Rush Medical School in Chicago, IL. He is immediate past editor of the Journal of Men’s Health and has published extensively in the field of urology. He is at present co-chair of the American Urological Association Guidelines panel for male sexual dysfunction and Peyronie’s Disease.

Christian Pavlovich

Christian Pavlovich

MD
Faculty

Biography

Dr. Christian P. Pavlovich is Professor of Urology at the Johns Hopkins University School of Medicine. He is the Director of Urological Oncology at Johns Hopkins Bayview Medical Center and Fellowship Director of Urologic Oncology for the Brady Urological Institute. His clinical focus is on prostate cancer, kidney cancer, and associated disorders, and on clinical trials regarding cancer detection, and surgical, ablative or immunologic treatment. He is experienced in performing open, laparoscopic and other minimally invasive surgeries for the management of urologic tumors, including robot-assisted laparoscopic radical prostatectomy, laparoscopic and robotic nephrectomy, nephroureterectomy, and partial nephrectomy. In addition, he offers patients active surveillance and ablative options for their urinary malignancies.

Keyan Salari

Keyan Salari

MD
Faculty

Biography

Dr. Salari is a urologic oncologist at the Massachusetts General Hospital and Instructor of Surgery at Harvard Medical School. He completed medical school at Stanford University School of Medicine, where he also earned a PhD in Genetics. He completed residency training in Urology at Massachusetts General Hospital and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center.

Ojas Shah

Ojas Shah

MD
Faculty

Biography

Dr. Ojas Shah is the George F. Cahill Professor of Urology at Columbia University College of Physicians and Surgeons. He also serves as the Director of the Division of Endourology and Stone Disease at Columbia University Medical Center. His clinical and research interests include surgical and metabolic treatments of kidney stone disease, minimally invasive urologic surgery, upper urinary tract urothelial carcinoma (transitional cell carcinoma), ureteral strictures, ureteropelvic junction (UPJ) obstruction, ureteral/renal reconstructive surgery, and BPH (benign prostate hyperplasia). He serves as the principal investigator in many clinical research trials regarding the surgical or medical management of stone disease.

Dr. Shah is a nationally and internationally recognized expert in the medical and surgical management of patients with urinary stone disease. He recently served as a member of the American Urological Association’s Surgical Management of Stones Guidelines Committee. He was also recently appointed to the American Board of Urology’s Examination Committee. He is an active member of the Endourological Society, EDGE (Endourology Disease Group for Excellence) Research Consortium, and ROCK (Research on Calculous Kinetics) Society.

Dr. Shah is an Assistant Editor for the Journal of Urology, the most highly cited and amongst the most respected international journals in the field. He is also co-editor of the 5th Edition of Taneja’s Complications of Urologic Surgery which was released in 2018.

Dr. Shah serves as the Director of the Endourology Fellowship at Columbia University Medical Center. He additionally has a strong focus on medical student and resident education, and served as the urology residency program director at NYU School of Medicine prior to joining Columbia.

Anton Wintner

Anton Wintner

MD
Faculty

Biography

AB- Harvard College
MD- Thomas Jefferson Medical College
Residency- Massachusetts General Hospital (Urology)
Fellowship- Duke University (Reconstructive and Prosthetic Urology)

Current Title:

Instructor in Surgery, Harvard Medical School
Assistant in Urology, Massachusetts General Hospital
Urology Residency Program Site Director, Newton Wellesley Hospital
Staff Urologist, Massachusetts General Hospital

Matthew Wszolek

Matthew Wszolek

MD
Faculty

Biography

Matthew F. Wszolek MD is a urologist at the Massachusetts General Hospital Department of Urology. He specializes in the treatment of urologic cancers and related research.

Dr. Wszolek is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. He finished his urology residency in 2011 and subsequently completed a fellowship in urologic oncology at MD Anderson Cancer Center. Dr. Wszolek’s clinical practice focuses on the surgical treatment of urologic cancers including bladder cancer, prostate cancer, kidney cancer and testicular cancer through the use of minimally invasive (laparoscopic and robotic) and open techniques. He is the department chair of Quality and Safety.